| Serial Number | 79084150 |
| Word Mark | CAP-T |
| Filing Date | Tuesday, May 11, 2010 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Monday, May 11, 2020 |
| Registration Number | 4036922 |
| Registration Date | Tuesday, October 11, 2011 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 26, 2011 |
| Goods and Services | Chemical, biological and biochemical additives, preparations and reagents for use in the manufacture of chemicals, biologicals and biochemicals, namely, preparations and reagents for non medical use, in particular for scientific, research, laboratory, industrial and commercial purposes; chemical, biological and biochemical additives, preparations and reagents for research and characterisation of diseases for non-medical purposes; chemical, biological and biochemical additives, preparations and reagents, namely, cell lines, cells, proteins and polypeptides, for scientific and medical research and development of pharmaceuticals; chemical, biological and biochemical additives, preparations and reagents for use in the manufacture of medicines and pharmaceuticals; cultures of microorganisms other than for medical and veterinary use; cell lines, cells and amino acids for laboratory or research use; nucleic acid sequences, proteins and polypaptides for other than medical and veterinary use; diagnostic reagents and preparations comprising proteins, polypeptides, nucleotides, nucleic acids, cell lines and cells for scientific, research, laboratory, and commercial purposes for the development of medicines and for use in the manufacture of medicines and pharmaceuticals |
| Goods and Services | Medicines, chemical, biological and biochemical preparations and proteins for the treatment of cancer, tumourous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardiovascular diseases, except thyreostatica and cough and cold medicines; pharmaceutical and veterinary preparations and reagents for use in the treatment of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases and cardio-vascular diseases, except thyreostatica and cough and cold medicines; chemical, biological and biochemical reagents for medical and veterinary purposes, except thyreostatica and cough and cold medicines; diagnostic and analytic preparations for medical and veterinary purposes; cell lines, cells, diagnostic proteins and polypeptides for medical or clinical use; nucleic acid sequences, diagnostic proteins, polypeptides and chemical reagents for medical and veterinary purposes; amino acids for medical or veterinary purposes; diagnostic reagents and preparations, namely, microorganisms, proteins, polypeptides, nucleotides, nucleic acids, cell lines and cells for medical, veterinary and diagnostic purposes, except thyreostatica and cough and cold medicines |
| Goods and Services | Scientific and industrial research, namely, in the fields of medicine, pharmaceuticals, molecular biology, biotechnology, immunology and genetics; research and development of medicines, diagnostic and analytic preparations, methods of therapy and expression systems; scientific and technological consulting services, namely, in the fields of medicine, pharmaceuticals, molecular biology, biotechnology, immunology and genetics; industrial consulting services, namely, consultancy pertaining to pharmacology; breeding, recovery, optimisation, synthesis and modification of cell culture lines, cells, microorganisms, polypeptides, proteins, nucleotides, nucleic acids for scientific, research, laboratory, industrial and commercial purposes, namely, for use in the fields of medicine, pharmaceuticals, molecular biology, biotechnology, immunology and genetics, for the development of medicines and for use in the manufacture of medicines and pharmaceuticals |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 18, 2018 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 18, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, May 18, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CEVEC Pharmaceuticals GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | 51105 Köln DE |
| Party Name | CEVEC Pharmaceuticals GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | 51105 Köln DE |
| Party Name | CEVEC Pharmaceuticals GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | 51105 Köln DE |
| Event Date | Event Description |
| Saturday, May 29, 2021 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| Saturday, May 29, 2021 | DEATH OF INTERNATIONAL REGISTRATION |
| Friday, March 15, 2019 | TOTAL INVALIDATION PROCESSED BY THE IB |
| Monday, January 28, 2019 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Monday, January 28, 2019 | INVALIDATION PROCESSED |
| Friday, January 18, 2019 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, May 18, 2018 | CANCELLED SECTION 71 |
| Monday, June 11, 2012 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, May 21, 2012 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, May 21, 2012 | FINAL DISPOSITION PROCESSED |
| Wednesday, January 11, 2012 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Monday, November 7, 2011 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Saturday, October 29, 2011 | LIMITATION OF GOODS RECEIVED FROM IB |
| Tuesday, October 11, 2011 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 26, 2011 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 26, 2011 | PUBLISHED FOR OPPOSITION |
| Monday, June 20, 2011 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, June 16, 2011 | ASSIGNED TO LIE |
| Thursday, June 9, 2011 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, June 9, 2011 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, June 9, 2011 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, June 9, 2011 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, June 9, 2011 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, June 7, 2011 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 6, 2011 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 6, 2011 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, February 18, 2011 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, February 18, 2011 | FINAL REFUSAL E-MAILED |
| Friday, February 18, 2011 | FINAL REFUSAL WRITTEN |
| Monday, February 7, 2011 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 7, 2011 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 7, 2011 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, January 21, 2011 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, January 21, 2011 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, October 5, 2010 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Saturday, September 25, 2010 | REFUSAL PROCESSED BY IB |
| Friday, September 24, 2010 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Monday, August 30, 2010 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, August 30, 2010 | REFUSAL PROCESSED BY MPU |
| Friday, August 27, 2010 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, August 26, 2010 | NON-FINAL ACTION WRITTEN |
| Thursday, August 19, 2010 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Wednesday, August 25, 2010 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| Tuesday, August 24, 2010 | ASSIGNED TO EXAMINER |
| Thursday, August 19, 2010 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Tuesday, July 27, 2010 | APPLICATION FILING RECEIPT MAILED |
| Friday, July 23, 2010 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, July 22, 2010 | SN ASSIGNED FOR SECT 66A APPL FROM IB |